Effectiveness of switching from nalfurafine to difelikefalin in patients with hemodialysis-associated pruritus: a prospective interventional study within a new treatment algorithm

Abstract Background Since June 2009, our facility has been using an internally developed treatment algorithm that facilitates a comprehensive approach to address each cause of hemodialysis-associated pruritus (HAP), wherein oral nalfurafine, a selective κ-opioid receptor (KOR) agonist, is used for p...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Naoko Takahashi, Taku Yoshizawa, Junko Kumagai, Hideki Kawanishi, Shinichiro Tsuchiya, Misaki Moriishi, Takao Masaki
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2025-07-01
Sarja:	Renal Replacement Therapy
Aiheet:	Hemodialysis-associated pruritus Quality of life Treatment algorithm Shiratori severity score Numerical rating scale Difelikefalin
Linkit:	https://doi.org/10.1186/s41100-025-00653-4
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!